Messoud Ashina MD PhD DMsc is Professor of Neurology, Danish Headache Center and Department of Neurology, University of Copenhagen, and has been involved into headache research since 1995. He completed his PhD in headache science focusing on tension-type headaches. Since 2006, he has been working on migraine and, in particular, experimental models of migraine. We had the […]
Meet the Expert: Messoud Ashina Read More »
MTIS 2022: September is a busy month for #MigraineAdvocacy The past weekend, the EMHA was part of the MTIS event, organized by The Migraine Trust, giving voice to all migraine sufferers around Europe. Watch the Opening Ceremony here: We also asked the visitors to sit on the chairs to raise awareness on the time to
EMHA is a full member of EPF since 2011. As the European Patient’s Forum states, members are the backbone of their work. Every single member has contributed and continues to contribute to making EPF the leading voice of patient organisations in Europe. Learn more on all of our partners About EPF The European Patients’ Forum (EPF) is
XPatient Barcelona Congress 2021 With the participation of EMHA. The XPatient Barcelona Congress is one of the main actions promoted by the XPA Barcelona (Patient Experience) – a community of practice that brings together institutions from the hospital, technology, research and administration fields – to transform the care model so that it places the patient
XPatient Barcelona Congress 2021 Read More »
Migraine in the EU: EMHA’s ‘Access to Care’ survey reveals shocking hurdles for patients to overcome and disparities in the EU. Presented at the Migraine in the EU: Lifting the barriers to treatment webinar. 29 September 2021, Brussels, Belgium. The European Migraine & Headache Alliance (EMHA) organised a webinar “Migraine in the EU: Lifting the
Migraine in the EU: Lifting the barriers to treatment Read More »
EMHA launches the first Migraine Friendly Workplace Stamp. This new initiative is designed to reduce the impact of migraine in the workplaceand recognizes companies that undertake EMHA training as well as making actionablechange in the workplace. Migraine affects over 41 million adults in Europe (prevalence 14%)1 and as migraine peaksduring individuals’ most productive years of
Migraine Friendly Workplace Stamp at work: The stamp that changes it all Read More »
As part of EFNA’s Training Initiatives for Neurology Advocates [TINA] programme, a new series of e-learning modules is launched today, on the theme of personalised healthcare. Personalised medicine is a medical model that aims to provide tailor-made prevention and treatment strategies for defined groups of individuals. This usually involves genomics, information technology and patient empowerment. However, at EFNA, we feel
New e-learning series on Personalized Healthcare: Women’s Brain Project Read More »
Three awards for the EMHA and The Migraine Movement, led by the EMHA, during this year. The EFNA advocacy awards announced the EMHA and Elena Ruiz de la Torre, executive director of the association, as the 2021 winner. This honorable recognition, puts on the spotlight all the hard work the EMHA has been doing to
Three awards for the EMHA Read More »
Within the documentary ‘Essentials: The role of patients’ associations in the health and social system in the COVID era by AEMICE’ we present a series of interviews with the associations. In this interview, AEMICE talks with Elena Ruiz de la Torre on the importance of the patient’s role in the health system. “We have been
Essentials by AEMICE: A series of interviews Read More »
EMHA scientific publications encourages and participates in research that adds value to our members, as well as to all migraine patients. The voice of patients needs to be represented in scientific migraine papers. By doing so, we are contributing to improving the possitive impact all the findings could have on the sufferers. Read the latest
EMHA scientific publications Read More »
Don't miss out on any updates! Join our community and discover
the latest research, treatments, and events on migraine.
Subscribe now!
